Fuan Pharmaceutical Group Co (300194) — Financial Flexibility Index
Fuan Pharmaceutical Group Co (300194) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥123.08 Million (operating CF CN¥100.27 Million minus capex CN¥22.81 Million) represents 0% of total liabilities (CN¥1.51 Billion). Check 300194 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fuan Pharmaceutical Group Co Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Fuan Pharmaceutical Group Co across 19 annual periods. For the full cash flow conversion analysis, see 300194 cash flow metrics.
Annual Financial Flexibility Index for Fuan Pharmaceutical Group Co (2007–2025)
Year-by-year free cash flow to debt coverage for Fuan Pharmaceutical Group Co. Explore Fuan Pharmaceutical Group Co (300194) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | CN¥420.76 Million | CN¥312.32 Million | CN¥1.40 Billion | ▼ -12.8% |
| 2024 | 0.35x | CN¥545.38 Million | CN¥303.59 Million | CN¥1.58 Billion | ▲ +15.8% |
| 2023 | 0.30x | CN¥544.66 Million | CN¥328.98 Million | CN¥1.83 Billion | ▼ -20.3% |
| 2022 | 0.37x | CN¥722.60 Million | CN¥339.50 Million | CN¥1.93 Billion | ▲ +2.7% |
| 2021 | 0.36x | CN¥670.16 Million | CN¥257.13 Million | CN¥1.84 Billion | ▲ +1.8% |
| 2020 | 0.36x | CN¥507.09 Million | CN¥162.55 Million | CN¥1.42 Billion | ▼ -48.6% |
| 2019 | 0.70x | CN¥519.42 Million | CN¥295.63 Million | CN¥746.59 Million | ▲ +4.2% |
| 2018 | 0.67x | CN¥399.84 Million | CN¥267.68 Million | CN¥598.62 Million | ▼ -35.7% |
| 2017 | 1.04x | CN¥537.99 Million | CN¥453.37 Million | CN¥518.24 Million | ▼ -14.7% |
| 2016 | 1.22x | CN¥528.08 Million | CN¥374.16 Million | CN¥434.00 Million | ▲ +64.8% |
| 2015 | 0.74x | CN¥253.19 Million | CN¥161.03 Million | CN¥342.91 Million | ▲ +283.1% |
| 2014 | 0.19x | CN¥24.03 Million | CN¥-31.27 Million | CN¥124.69 Million | ▼ -89.8% |
| 2013 | 1.89x | CN¥261.58 Million | CN¥89.61 Million | CN¥138.47 Million | ▼ -18.5% |
| 2012 | 2.32x | CN¥195.21 Million | CN¥62.77 Million | CN¥84.20 Million | ▲ +74.4% |
| 2011 | 1.33x | CN¥165.78 Million | CN¥64.85 Million | CN¥124.69 Million | ▼ -50.4% |
| 2010 | 2.68x | CN¥174.48 Million | CN¥105.74 Million | CN¥65.09 Million | ▲ +215.3% |
| 2009 | 0.85x | CN¥93.79 Million | CN¥62.75 Million | CN¥110.31 Million | ▼ -6.7% |
| 2008 | 0.91x | CN¥83.71 Million | CN¥49.23 Million | CN¥91.83 Million | ▲ +97.5% |
| 2007 | 0.46x | CN¥33.50 Million | CN¥18.92 Million | CN¥72.58 Million | — |